AVEO Oncology Reports First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
AVEO Oncology (AVEO) Misses Q1 EPS by 5c
May 5, 2022 7:14 AM EDTAVEO Oncology (NASDAQ: AVEO) reported Q1 EPS of ($0.30), $0.05 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $20.9 million versus the consensus estimate of $20.65 million.
GUIDANCE:
AVEO Oncology sees FY2022 revenue of $100-110 million.
For earnings history and earnings-related data on AVEO Oncology (AVEO) click here.
... More